Credibility via FDA approval may be key for digital health startup success

Perhaps more important to a healthcare startup’s business sustainability than the potential for disruption is its trust and credibility among stakeholders. And in healthcare, this may stem from acquiring FDA approval, according to a contributed Tech Crunch post from Min-Sung Sean Kim, a partner at German venture capital investor XLHEALTH.

Advertisement

Mr. Kim writes that while trust and credibility are crucial for all startups, these traits may carry more weight in the healthcare industry, which deals with sensitive topics and providers are more wary of new companies due to healthcare’s complexities and heightened regulation.

In order to prove a product or service is credible and trustworthy, Mr. Kim suggests acquiring approval or certifications. He outlines the story of mySugr, a Vienna-based startup focusing on diabetes therapy. “Meeting FDA/EU standards was a top priority from the very beginning. The company wanted to make it very clear to stakeholders that it was offering a medical product solving a real therapy problem, as opposed to a wellness gadget,” Mr. Kim writes.

Having such backing can lead to more valuable relationships with potential clients like payers and providers, as well as higher retention rates, Mr. Kim writes.

More articles on startups:

Harsher reality on the horizon for ‘unicorn’ startups, report suggests 
How a former NFL quarterback got into the world of health IT startups 
University of Washington names 3 startups Health Innovation Challenge winners 

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.